Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.

Nature·2017
Same author

Elucidating crosstalk mechanisms between phosphorylation and O-GlcNAcylation.

Proceedings of the National Academy of Sciences of the United States of America·2017
Same author

Natural products triptolide, celastrol, and withaferin A inhibit the chaperone activity of peroxiredoxin I.

Chemical science·2017
Same author

A community proposal to integrate proteomics activities in ELIXIR.

F1000Research·2017
Same author

3-Hydroxybenzoate 6-Hydroxylase from <i>Rhodococcus jostii</i> RHA1 Contains a Phosphatidylinositol Cofactor.

Frontiers in microbiology·2017
Same author

Erratum: Microtubule minus-end regulation at spindle poles by an ASPM-katanin complex.

Nature cell biology·2017

Related Experiment Video

Updated: Jun 23, 2026

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing (Frog) Embryo
09:18

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing (Frog) Embryo

Published on: April 21, 2022

Proteomics and human embryonic stem cells.

Dennis Van Hoof1, Albert J R Heck, Jeroen Krijgsveld

  • 1Developmental Biology and Stem Cell Research, Hubrecht Institute, Utrecht, The Netherlands.

Stem Cell Research
|April 23, 2009
PubMed
Summary

Proteomics using mass spectrometry identifies key proteins for human embryonic stem cell (hESC) self-renewal and pluripotency. This research advances cell therapy by revealing novel intracellular and extracellular factors influencing hESC behavior.

More Related Videos

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
09:03

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR

Published on: May 29, 2014

Chromatin Immunoprecipitation from Human Embryonic Stem Cells
10:36

Chromatin Immunoprecipitation from Human Embryonic Stem Cells

Published on: July 22, 2008

Related Experiment Videos

Last Updated: Jun 23, 2026

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing (Frog) Embryo
09:18

Cell-Lineage Guided Mass Spectrometry Proteomics in the Developing (Frog) Embryo

Published on: April 21, 2022

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
09:03

Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR

Published on: May 29, 2014

Chromatin Immunoprecipitation from Human Embryonic Stem Cells
10:36

Chromatin Immunoprecipitation from Human Embryonic Stem Cells

Published on: July 22, 2008

Area of Science:

  • Stem Cell Biology
  • Proteomics
  • Regenerative Medicine

Background:

  • Human embryonic stem cells (hESCs) are crucial for regenerative medicine, but controlling their expansion and differentiation is challenging due to unknown signaling pathways.
  • Current methods like microarrays provide gene expression data, but protein-level information, including post-translational modifications, is essential for understanding cellular functions.

Purpose of the Study:

  • To review and analyze proteomic studies on hESCs and feeder cells to identify proteins critical for hESC maintenance and pluripotency.
  • To complement transcriptome data with proteome-wide insights into hESC behavior and signaling.

Main Methods:

  • Utilized mass spectrometry-based proteomic techniques to analyze hESCs and conditioned media from feeder cells.
  • Performed a meta-analysis of published proteomic datasets from multiple hESC lines and feeder cell types (mouse and human).

Main Results:

  • Identified 32 intracellular and 16 plasma membrane proteins consistently found in undifferentiated hESCs but not in differentiated cells.
  • Discovered 13 and 24 proteins commonly present in mouse and human feeder cell lines, respectively, potentially acting as extracellular signaling molecules.

Conclusions:

  • Mass spectrometry-based proteomics is a powerful, unbiased approach for discovering novel proteins associated with hESCs.
  • Proteomic data provides crucial insights into the molecular mechanisms governing hESC self-renewal, pluripotency, and interaction with feeder cells, advancing cell therapy development.